Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bionano Genomics

3.75
+0.07001.90%
Post-market: 3.750.00000.00%19:51 EDT
Volume:49.87K
Turnover:186.60K
Market Cap:12.62M
PE:-0.04
High:3.78
Open:3.75
Low:3.70
Close:3.68
Loading ...

Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025

GlobeNewswire
·
14 Mar

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview

Reuters
·
11 Mar

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview

Reuters
·
06 Mar

Stock Track | Bionano Genomics Plunges 5.02% as Earnings Preview Signals Losses and Revenue Decline

Stock Track
·
01 Mar

Bionano Genomics Inc expected to post a loss of $6.00 a share - Earnings Preview

Reuters
·
01 Mar

Bionano Genomics : May Offer, Sell Shares of Common Stock of up to $75 Mln From Time to Time

THOMSON REUTERS
·
22 Feb

BRIEF-Bionano Genomics Inc - On February 4, Terminates Sales Agreement With Cowen Effective February 14, 2025

Reuters
·
11 Feb

Bionano Genomics Inc - on February 4, Terminates Sales Agreement With Cowen Effective February 14, 2025

THOMSON REUTERS
·
11 Feb

BioNano Genomics Executes Significant Reverse Stock Split

TIPRANKS
·
28 Jan

Bionano Genomics trading halted, news pending

TIPRANKS
·
25 Jan

Stock Track | Bionano Genomics Plunges 16.39% on Reverse Stock Split Announcement

Stock Track
·
23 Jan

Stock Track | Bionano Genomics Plunges 5.66% in Pre-Market Trading After Announcing 1-for-60 Reverse Stock Split

Stock Track
·
23 Jan

Bionano Genomics to Implement 1-for-60 Reverse Stock Split

MT Newswires Live
·
23 Jan

Stock Track | Bionano Genomics Plunges 9.38% After-hours Following Reverse Stock Split Announcement

Stock Track
·
23 Jan

BRIEF-Bionano Announces Effective Date Of Reverse Stock Split

Reuters
·
23 Jan

Bionano Announces Effective Date of Reverse Stock Split

THOMSON REUTERS
·
23 Jan

Stock Track | Bionano Genomics Plummets Over 5% on Disappointing Q4 2024 Revenue Outlook and Full Year Decline

Stock Track
·
13 Jan

BRIEF-Bionano Genomics Preliminary Q4 2024 Revenue Expected To Be $7.9-$8.1 Million

Reuters
·
13 Jan

Stock Track | Bionano Genomics Surges 5.16% on OGM Growth and Cost Cutting Efforts

Stock Track
·
13 Jan

Bionano Genomics Inc - Full Year 2024 Revenue Expected to Be $30.5-$30.7 Million

THOMSON REUTERS
·
13 Jan